Skip to main content
Délia Boino
Submitted by dboino on 16 March 2021
Intended learning outcomes
  1. Knowledge of Bio-pharmaceutical substances as innovative therapeutic way in present clinical practice.
  2. Adquire the basis of human gene therapy, including vectors and systems used for the applied examples, overview its limitations and advantages over conventional therapies.
  3. Review the basis for pharmacogenomics personalized therapy as well as the advantages and limitations associated with this technology.
  4. Cell therapy and tissue engineering main strategies applied to regenerative medicine.
  5. Raising awareness of bioethical issues associated with genetic testing, gene therapy, pharmacogenomics, regenerative medicine and protection of intellectual property in biotechnology products and processes.

 

Curricular Unit Form